AwardedSpainGoodsFramework agreement€1,136,640
Suministro de medicamento INMUNOGLOBULINA HUMANA NORMAL ENDOVENOSA con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid.
- Published
- Published 1 September 2025
- Deadline
- Closed 30 September 2025
Overview
Suministro de medicamento INMUNOGLOBULINA HUMANA NORMAL ENDOVENOSA con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €1,136,640
- Procedure
- Open
- Contract type
- Framework agreement
- SME suitable
- Yes
- Published
- 1 September 2025
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- €2,825,987
- Award date
- 20 January 2026
- Contract period
- — → 4 January 2029
- CSL BEHRING, S.A.
- OCTAPHARMA, S.A.
- Takeda Farmacéutica España S.A.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
26 January 2026
Contract Notice
1 September 2025
Contracting authority
HOSPITAL CLINICO SAN CARLOS
Procuring entityMadrid, Spain
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.